These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 6100648)

  • 41. Screening for antibody to HTLV-III in blood donors of Liguria. Ligurian Committee for the Study of Infections Transmitted through Blood and Blood Products.
    Boll Ist Sieroter Milan; 1985; 64(5):363-6. PubMed ID: 3004542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acquired immunodeficiency syndrome (AIDS). An update after 4 years].
    Vogt M; Lüthy R; Siegenthaler W
    Schweiz Med Wochenschr; 1985 May; 115(19):665-71. PubMed ID: 2988117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
    Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS
    J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
    Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
    Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology of human lymphotrophic retroviruses: an overview.
    Blattner WA; Biggar RJ; Weiss SH; Clark JW; Goedert JJ
    Cancer Res; 1985 Sep; 45(9 Suppl):4598s-4601s. PubMed ID: 2990691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
    Kaplan MH; Pahwa SG; Popovic M; Sarngadharan MG; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kaplan memorial lecture. The family of human lymphotropic retroviruses called HTLV: HTLV-I in adult T-cell leukemia (ATL), HTLV-II in hairy cell leukemias, and HTLV-III in AIDS.
    Gallo RC
    Princess Takamatsu Symp; 1984; 15():13-38. PubMed ID: 6100633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HTLV: epidemiology and relationship to disease.
    Blattner WA; Clark JW; Gibbs WN; Williams CK; Nomura A; Mann D; Saxinger C; Robert-Guroff M; Gallo RC
    Princess Takamatsu Symp; 1984; 15():93-108. PubMed ID: 6100653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
    Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
    AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.
    Ho DD; Rota TR; Schooley RT; Kaplan JC; Allan JD; Groopman JE; Resnick L; Felsenstein D; Andrews CA; Hirsch MS
    N Engl J Med; 1985 Dec; 313(24):1493-7. PubMed ID: 2999591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome.
    Borek E; Sharma OK; Buschman FL; Cohn DL; Penley KA; Judson FN; Dobozin BS; Horsburgh CR; Kirkpatrick CH
    Cancer Res; 1986 May; 46(5):2557-61. PubMed ID: 3008993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
    Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
    AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transmission of acquired immune deficiency syndrome (AIDS) by a blood transfusion given in 1979 in Israel.
    Kleinman Y; Yust I; Maayan S; Rave D; Merdler C; Michaeli D; Schlesinger M
    Isr J Med Sci; 1986 May; 22(5):404-7. PubMed ID: 3017890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis?
    Osterholm MT; Bowman RJ; Chopek MW; McCullough JJ; Korlath JA; Polesky HF
    N Engl J Med; 1985 May; 312(18):1185-9. PubMed ID: 2984568
    [No Abstract]   [Full Text] [Related]  

  • 55. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
    Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M
    Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
    Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA
    JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
    Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
    Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
    Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Seroepidemiology of the HTLV-III virus in a high-risk Panamanian population. Preliminary report].
    Arosemena JR; Cuevas M; Ulloa E; Guerrero DM; Gómez B; Cantón-Dutary A; Reyes R; Quiroz E; de Britton RM; Brenes MM
    Rev Med Panama; 1986 May; 11(2):124-33. PubMed ID: 3018847
    [No Abstract]   [Full Text] [Related]  

  • 60. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.